HIV immune complexes prevent excitotoxicity by interaction with NMDA receptors

Neurobiology of Disease

Volumn 49, Issue 1, 2013, Pages 169-176

  Rumbaugh, Jeffrey A ^a   Bachani, Muznabanu ^b   Li, Wenxue ^b,e   Butler, Tracy R ^c   Smith, Katherine J ^c   Bianchet, Mario A ^b,d   Wang, Tongguang ^b,e   Prendergast, Mark A ^c   Sacktor, Ned ^b   Nath, Avindra ^b,e  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Dementia; Glutamate; Neuroprotection; Neurotoxicity; Neurovirology; Neutralizing antibodies

Indexed keywords

GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TRANSACTIVATOR PROTEIN; AMPA RECEPTOR; ANTIBODY; ANTIGEN ANTIBODY COMPLEX; KAINIC ACID RECEPTOR;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; EMBRYO; EXCITOTOXICITY; FEMALE; FETUS; HIV ASSOCIATED DEMENTIA; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPRECIPITATION; MALE; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; AGONISTS; ANIMAL; BRAIN CORTEX; CELL CULTURE; COCULTURE; DRUG EFFECTS; GENE DELETION; GENETICS; GLIA; HIPPOCAMPUS; IMMUNOLOGY; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT; TISSUE CULTURE TECHNIQUE;

ANIMALS; ANTIBODIES; ANTIGEN-ANTIBODY COMPLEX; CELLS, CULTURED; CEREBRAL CORTEX; COCULTURE TECHNIQUES; FEMALE; HIPPOCAMPUS; HUMANS; MALE; NEUROGLIA; NEURONS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; RECEPTORS, N-METHYL-D-ASPARTATE; SEQUENCE DELETION; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TISSUE CULTURE TECHNIQUES;

EID: 84866526688     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.08.013     Document Type: Article

References (34)

1. Anthony I.C., Crawford D.H., Bell J.E. B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas. Brain 2003, 126:1058-1067.
2. Anthony I.C., Ramage S.N., Carnie F.W., Simmonds P., Bell J.E. Influence of HAART on HIV-related CNS disease and neuroinflammation. J. Neuropathol. Exp. Neurol. 2005, 64:529-536.
3. Ardoin S.P., Pisetsky D.S. Developments in the scientific understanding of lupus. Arthritis Res. Ther. 2008, 10:218.
4. Caporello E., Nath A., Slevin J., Galey D., Hamilton G., Williams L., et al. The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV-1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load. J. Neurochem. 2006, 98:146-155.
5. Cawley L.P., Minard B.J., Tourtellotte W.W., Ma B.I., Chelle C. Immunofixation electrophoretic techniques applied to identification of proteins in serum and cerebrospinal fluid. Clin. Chem. 1976, 22:1262-1268.
6. Cojocaru M., Cojocaru M.I., Steriu O., Baldescu R. Changes of circulating immune complexes in the serum and CSF of patients with multiple sclerosis. Rom. J. Intern. Med. 1992, 30:51-56.
7. During M.J., Symes C.W., Lawlor P.A., Lin J., Dunning J., Fitzsimons H.L., et al. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science 2000, 287:1453-1460.
8. Fainardi E., Contini C., Benassi N., Bedetti A., Castellazzi M., Vaghi L., et al. Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders. J. Neuroimmunol. 2001, 119:278-286.
9. Haughey N.J., Nath A., Mattson M.P., Slevin J.T., Geiger J.D. HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J. Neurochem. 2001, 78:457-467.
10. Heaton R.K., Franklin D.R., Ellis R.J., McCutchan J.A., Letendre S.L., Leblanc S., et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J. Neurovirol. 2011, 17:3-16.
11. Jaffrey S.R., Snyder S.H. The biotin switch method for the detection of S-nitrosylated proteins. Sci. STKE 2001, PL1.
12. Langford T.D., Letendre S.L., Larrea G.J., Masliah E. Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol. 2003, 13:195-210.
13. Li W., Huang Y., Reid R., Steiner J., Malpica-Llanos T., Darden T.A., et al. NMDA receptor activation by HIV-Tat protein is clade dependent. J. Neurosci. 2008, 28:12190-12198.
14. Ma M., Nath A. Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J. Virol. 1997, 71:2495-2499.
15. Magnuson D.S., Knudsen B.E., Geiger J.D., Brownstone R.M., Nath A. Human immunodeficiency virus type 1 tat activates non-N-methyl-d-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 1995, 37:373-380.
16. Mulholland P.J., Prendergast M.A. Transection of intrinsic polysynaptic pathways reduces N-methyl-d-aspartate neurotoxicity in hippocampal slice cultures. Neurosci. Res. 2003, 46:369-376.
17. Nath A., Psooy K., Martin C., Knudsen B., Magnuson D.S., Haughey N., et al. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 1996, 70:1475-1480.
18. Nath A., Haughey N.J., Jones M., Anderson C., Bell J.E., Geiger J.D. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann. Neurol. 2000, 47:186-194.
19. Poignard P., Klasse P.J., Sattentau Q.J. Antibody neutralization of HIV-1. Immunol. Today 1996, 17:239-246.
20. Prendergast M.A., Rogers D.T., Mulholland P.J., Littleton J.M., Wilkins L.H., Self R.L., et al. Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-d-aspartate receptor. Brain Res. 2002, 954:300-307.
21. Prendergast M.A., Harris B.R., Mullholland P.J., Blanchard J.A., Gibson D.A., Holley R.C., et al. Hippocampal CA1 region neurodegeneration produced by ethanol withdrawal requires activation of intrinsic polysynaptic hippocampal pathways and function of N-methyl-d-aspartate receptors. Neuroscience 2004, 124:869-877.
22. Pul R., Dodel R., Stangel M. Antibody-based therapy in Alzheimer's disease. Expert. Opin. Biol. Ther. 2011, 11:343-357.
23. Rastogi S.C., Clausen J., Hansen H.J., Pedersen E., Tourtellotte W.W. Estimation of levels of IgG to multiple sclerosis specific brain antigens in the cerebrospinal fluid of MS patients. Neurochem. Res. 1983, 8:1261-1269.
24. Rezza G., Fiorelli V., Dorrucci M., Ciccozzi M., Tripiciano A., Scoglio A., et al. The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters. J. Infect. Dis. 2005, 191:1321-1324.
25. Ruckwardt T.J., Tikhonov I., Berg S., Hatfield G.S., Chandra A., Chandra P., et al. Sequence variation within the dominant amino terminus epitope affects antibody binding and neutralization of human immunodeficiency virus type 1 Tat protein. J. Virol. 2004, 78:13190-13196.
26. Rudick R.A., Bidlack J.M., Knutson D.W. Multiple sclerosis. Cerebrospinal fluid immune complexes that bind C1q. Arch. Neurol. 1985, 42:856-858.
27. Self R.L., Smith K.J., Butler T.R., Pauly J.R., Prendergast M.A. Intra-cornu ammonis 1 administration of the human immunodeficiency virus-1 protein trans-activator of transcription exacerbates the ethanol withdrawal syndrome in rodents and activates N-methyl-d-aspartate glutamate receptors to produce persisting spatial learning deficits. Neuroscience 2009, 163:868-876.
28. Stoppini L., Buchs P.A., Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 1991, 37:173-182.
29. Tahirov T.H., Babayeva N.D., Varzavand K., Cooper J.J., Sedore S.C., Price D.H. Crystal structure of HIV-1 Tat complexed with human P-TEFb. Nature 2010, 465:747-751.
30. Tikhonov I., Ruckwardt T.J., Hatfield G.S., Pauza C.D. Tat-neutralizing antibodies in vaccinated macaques. J. Virol. 2003, 77:3157-3166.
31. Toothaker T.B., Rubin M. Paraneoplastic neurological syndromes: a review. Neurologist 2009, 15:21-33.
32. Trujillo J.R., Navia B.A., Worth J., Lucey D.R., McLane M.F., Lee T.H., et al. High levels of anti-HIV-1 envelope antibodies in cerebrospinal fluid as compared to serum from patients with AIDS dementia complex. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1996, 12:19-25.
33. Turchan J., Anderson C., Hauser K.F., Sun Q., Zhang J., Liu Y., et al. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci. 2001, 2:3.
34. Wajgt A., Gorny M. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies. Acta Neurol. Scand. 1983, 68:337-343.